These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1547574)

  • 1. Analysis of commonly abused drugs in urine at selected threshold (cutoff) concentrations.
    Watson ID
    Clin Chem; 1992 Mar; 38(3):441. PubMed ID: 1547574
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of creatinine analyses of urine when screening for abused drugs.
    Lafolie P; Beck O; Blennow G; Boréus L; Borg S; Elwin CE; Karlsson L; Odelius G; Hjemdahl P
    Clin Chem; 1991 Nov; 37(11):1927-31. PubMed ID: 1934467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride.
    Birch MA; Couchman L; Pietromartire S; Karna T; Paton C; McAllister R; Marsh A; Flanagan RJ
    J Anal Toxicol; 2013 May; 37(4):233-6. PubMed ID: 23471956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic assays for detecting lactose and sucrose in urine to reveal intravenous drug abuse with emphasis on buprenorphine.
    Keltanen T; Mariottini C; Walta AM; Rahikainen AL; Ojanperä I
    Drug Test Anal; 2017 Jun; 9(6):949-952. PubMed ID: 27504930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme immunoassay validation for the detection of buprenorphine in urine.
    Cirimele V; Kintz P; Lohner S; Ludes B
    J Anal Toxicol; 2003 Mar; 27(2):103-5. PubMed ID: 12670004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine.
    Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS
    J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis for commonly abused drugs in urine at selected threshold ("cutoff") concentrations.
    Finkle BS; Black D; Blanke RV; Butler TJ; Jones GR; Sample RH
    Clin Chem; 1991 Apr; 37(4):586-7. PubMed ID: 2015681
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a fluoroimmunoassay for the detection of buprenorphine in urine.
    Debrabandere L; Van Boven M; Daenens P
    J Forensic Sci; 1995 Mar; 40(2):250-3. PubMed ID: 7602287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three commercial tests for buprenorphine screening in urine.
    Leino A; Loo BM
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic assay for urine lactose in the assessment of recent intravenous abuse of buprenorphine.
    Keltanen TN; Heikman PK; Muhonen LH; Gunnar TO; Ojanperä IA
    Drug Test Anal; 2019 Sep; 11(9):1412-1418. PubMed ID: 31140750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry.
    Kronstrand R; Seldén TG; Josefsson M
    J Anal Toxicol; 2003 Oct; 27(7):464-70. PubMed ID: 14607001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis for a stable patient maintained on buprenorphine who gives a urine toxicology screen negative for buprenorphine.
    Sethi R; Petrakis I
    Am J Addict; 2014; 23(3):318-9. PubMed ID: 24724891
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens.
    Cirimele V; Etienne S; Villain M; Ludes B; Kintz P
    Forensic Sci Int; 2004 Jul; 143(2-3):153-6. PubMed ID: 15240036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and GC-MS validation of a highly sensitive recombinant G6PDH-based homogeneous immunoassay for the detection of buprenorphine and norbuprenorphine in urine.
    Wang G; Vincent M; Rodrigues W; Agrawal A; Moore C; Barhate R; Abolencia E; Coulter C; Soares J; Zheng YF; Taylor C; Morjana N
    J Anal Toxicol; 2007 Sep; 31(7):377-82. PubMed ID: 17725885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of buprenorphine in urine: immunoassay versus LC-MS/MS.
    Twigger S; Fox E; Allen K
    Ann Clin Biochem; 2008 May; 45(Pt 3):339. PubMed ID: 18482930
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry.
    Vincent F; Bessard J; Vacheron J; Mallaret M; Bessard G
    J Anal Toxicol; 1999; 23(4):270-9. PubMed ID: 10445490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papain: a novel urine adulterant.
    Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
    J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.